<unk>  (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo<unk>  decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point. It has been said that "α-emitters are indispensable with regard to optimisation of strategies for tumour therapy".
Targeted alpha-particle therapy
Targeted therapy
Transcatheter arterial chemoembolization
Sequential high-dose chemotherapy
Radionuclide therapy
Multisystemic therapy
Combination therapy
Chemoradiotherapy